ReviewPharmacology & therapeutics2020

Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy.

Michael-Joseph Gorbet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.